Stay updated on Poly-ICLC and Anti-PD1 Combo in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Poly-ICLC and Anti-PD1 Combo in Melanoma Clinical Trial page.

Latest updates to the Poly-ICLC and Anti-PD1 Combo in Melanoma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5, indicating a small version update to the page. It does not change study content, eligibility criteria, or results; it is a background maintenance update.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page's revision tag was updated from v3.6.3 to v3.6.4, representing a minor update to the page version and accompanying content or formatting.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page's revision label was updated to v3.6.3, indicating a newer version of the page; this appears to be a minor metadata update rather than a change to study details.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page now displays Revision: v3.6.2, replacing Revision: v3.6.0 as part of a small site update to the page's version metadata.SummaryDifference0.1%

- Check73 days agoChange DetectedThe page now indicates the study is not recruiting participants, reflecting a recruitment status change. It also adds navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the revision tag to v3.6.0.SummaryDifference0.6%

- Check80 days agoChange DetectedThe page now displays Revision: v3.5.5 instead of Revision: v3.5.4, indicating an updated release tag for the page.SummaryDifference0.1%

Stay in the know with updates to Poly-ICLC and Anti-PD1 Combo in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Poly-ICLC and Anti-PD1 Combo in Melanoma Clinical Trial page.